글로벌 동물 항생제 항균제 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

동물 항생제 항균제 시장 분석

지난 몇 년 동안 동물성 식품 소비가 증가했고, 유제품에 대한 수요가 증가했으며, 조직적인 농장으로 인해 가축 개체 수가 증가했습니다. 이러한 결정 요인은 동물 항생제 항균제에 대한 수요를 더욱 촉진합니다. 전체 반려동물 개체 수, 특히 중국, 인도, 브라질의 증가는 예상 기간 동안 시장이 상당히 확대되는 결과를 가져왔습니다.

동물 항생제 항균제 시장 규모

글로벌 동물 항생제 항미생물제 시장 규모는 2023년에 48억 8천만 달러로 평가되었으며, 2031년까지 67억 3천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 4.10%입니다.

보고 범위 및 시장 세분화       

동물 항생제 항균제 시장 정의

Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic.  Antimicrobials offer significant advantages in terms of animal and human food safety. Antibiotics and antimicrobials used in animals can contribute to the spread of antimicrobial resistance in bacteria that can be transmitted to people, reducing the efficacy of antimicrobial medications for treating human illnesses.

Animal Antibiotics Antimicrobials Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Concerns For the Animal Health

There has been rising concerns regarding the health of animals. The rising animal healthcare spending and the growing demand for pet insurance will lead to high demand for animal antibiotics antimicrobials, which is the most significant factor driving the growth for this market. Increasing initiatives concerning animal health and welfare along with increasing incidence of zoonotic diseases are also expected to accelerate the overall growth of the market.

Furthermore, the rapid growth in the consumption of products such as meat and seafood on regular basis also triggers the market growth. The rising demand for animal-derived food products and the implementation of regulations to prevent the spread of animal diseases are also projected to cushion the growth of the market. Moreover, the unused prospects of the advancing markets and the development in the companion animal populace are estimated to generate lucrative opportunities for the market. The surging demand for dairy products, and subsequent rise in livestock population facilitated by organized farming which will further expand the animal antibiotics antimicrobials market's growth rate in the future.

Restraints/Challenges

• Strict Acceptance Process

There has been the increasing resistance to the antimicrobials. The strict acceptance procedure for the antimicrobials and antibiotics is expected to create hindrances for the market growth.

Also, the factors such as the shortage of the new antibiotics and the repetitive preventive utilization of the antibiotics being substituted by the good husbandry and the sanitization practices are projected to challenge the animal antibiotics antimicrobials market in the forecast period of 2024-2031.

This animal antibiotics antimicrobials market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the animal antibiotics antimicrobials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Animal Antibiotics Antimicrobials Market

The animal antibiotics antimicrobials market was moderately impacted by the outbreak of COVID-19. Imposition of the stringent lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various manufacturing operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the industry's expansion. The adoption of alternative sources, such as plant-based ingredients also hindered the growth of the market.

Moreover, the surge in Antimicrobial Resistance (AMR) in people and animals is projected in the post-COVID scenario, owing to increased demand on antibiotic-dependent healthcare systems to treat secondary bacterial infections. Antibiotic stewardship initiatives in hospitals and communities were interrupted, and antibiotics were prescribed for COVID patients misdiagnosed with bacterial bronchitis, over-prescription in telehealth consultations, and easy access to drugs from internet pharmacies were all linked to AMR. This is resulted in negative impact on consumers toward animal-sourced products.

Animal Antibiotics Antimicrobials Market Scope

The animal antibiotics antimicrobials market is segmented on the basis of product, mode of delivery and animal type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Tetracycline
• Penicillin
• Sulfonamide
• Macrolide
• Cephalosporin
• Fluoroquinolone
• Lincosamides
• Cephalosporins

On the basis of product, the animal antibiotics antimicrobials market is segmented into tetracycline, penicillin, sulfonamide, macrolide, cephalosporin, fluoroquinolone, lincosamides and cephalosporins. The tetracyclines segment accounts for the largest share owing to its factors such as well-absorbed, low toxicity, high potency against pathogenic microorganisms and are relatively inexpensive compared to other animal antimicrobial and antibiotic products.

Mode of Delivery

• Premixes
• Oral Powder
• Injection
• Others

On the basis of mode of delivery, the animal antibiotics antimicrobials market is segmented into premixes, oral powder, injection and others.

Animal Type

• Food-producing Animals
• Companion Animals

On the basis of animal type, the animal antibiotics antimicrobials market is bifurcated into food-producing animals and companion animals.

Animal Antibiotics Antimicrobials Market Regional Analysis

The animal antibiotics antimicrobials market is analyzed and market size insights and trends are provided by country, product, mode of delivery and animal type as referenced above.

The countries covered in the animal antibiotics antimicrobials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the animal antibiotics antimicrobials market because of the high companion animal ownership, increasing incidences of animal diseases coupled with the huge capital investments for the development of drugs for animal diseases within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing government involvement in countering animal diseases outbreaks, increasing livestock population along with the growing demand for animal antimicrobials within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

의료 인프라 성장 설치 기반 및 신기술 침투

동물 항생제 항균제 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 동물 항생제 항균제 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 동물 항생제 항균제 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

동물 항생제 항균제 시장 점유율

동물 항생제 항균제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 동물 항생제 항균제 시장과 관련된 회사의 초점에만 관련이 있습니다.

동물 항생제 항균제 시장 리더는 시장에서 운영되고 있습니다:

• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• 조에티스(미국)
• 엘란코(미국)
• 머크앤코(미국)
• Phibro Animal Health Corporation (미국)
• 비르박(프랑스)
• 베토퀴놀(프랑스)
• HIPRA(스페인)
• 세바(프랑스)
• 데크라(영국)
• Kyoritsuseiyaku Corporation(일본)
• 중국 동물 사육 그룹(중국)
• 엔도백 애니멀 헬스(미국)
• Zydus 그룹(인도)
• Indian Immunologicals Pvt. Ltd. (인도)
• UCBVET Saúde e Bem Estar Animal(미국)
• American Reagent Inc. (미국)
• 네오젠 코퍼레이션(미국)
• 휴베파마(미국)
• 아유르베트(인도)
• Ashish Life Science(인도)
• Inovet Group(벨기에)
• Lutim Pharma Private Limited(인도)
• ECO 애니멀 헬스 유한회사 (미국)

동물 항생제 항균제 시장의 최신 동향

• 2020년 7월, Trianni Inc.(미국)와 Zoetis(미국)는 새로운 수의학 의약품을 식별하기 위한 형질전환 단일클론 항체 플랫폼 개발에 협력하기로 합의했습니다. FDA는 Zoetis(미국)에 대한 Marboquin 구매를 승인했습니다.

SKU-10577